When calculating COVID-19 incidence, mandatory PCR testing should be preferred over voluntary antigen testing
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of the Formosan Medical Association = Taiwan yi zhi - (2024) vom: 12. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Finsterer, Josef [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 13.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.jfma.2024.04.005 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM371042216 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM371042216 | ||
003 | DE-627 | ||
005 | 20240415232547.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240415s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jfma.2024.04.005 |2 doi | |
028 | 5 | 2 | |a pubmed24n1375.xml |
035 | |a (DE-627)NLM371042216 | ||
035 | |a (NLM)38614908 | ||
035 | |a (PII)S0929-6646(24)00205-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Finsterer, Josef |e verfasserin |4 aut | |
245 | 1 | 0 | |a When calculating COVID-19 incidence, mandatory PCR testing should be preferred over voluntary antigen testing |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
650 | 4 | |a Letter | |
650 | 4 | |a Antigen testing | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Incidence | |
650 | 4 | |a RT-PCR | |
650 | 4 | |a SARs-CoV-2 | |
773 | 0 | 8 | |i Enthalten in |t Journal of the Formosan Medical Association = Taiwan yi zhi |d 1992 |g (2024) vom: 12. Apr. |w (DE-627)NLM012627941 |x 0929-6646 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:12 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jfma.2024.04.005 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 12 |c 04 |